Bristol Myers Squibb Protein Degrader Wins First-in-Class FDA Nod in Multiple MyelomaNews DeskAugust 14, 20260 A Bristol Myers Squibb drug has received accelerated FDA approval for treating multiple myeloma, a decision that introduces a new…